Results 131 to 140 of about 6,220 (295)

Xénogreffe d'îlots de Langerhans dans le diabète non autoimmun (intérêt du transfert de gène de molécules immunosuppressives dans les modèles porc/rat et rat/souris)

open access: yes, 2002
La greffe d'îlots de Langerhans serait pour les patients diabétiques une solution plus physiologique que l'insulinothérapie dont la généralisation sera, malgré son efficacité, limitée par le nombre d'îlots disponibles à partir de pancréas de donneur, et ...
LE MAUFF-QUESTER, Brigitte   +1 more
core  

Ionizable Lipid‐Dependent Optimization of Steroid Lipid Nanoparticles With Tunable Immunomodulatory Properties

open access: yesAdvanced Materials, EarlyView.
A novel engineering strategy that establishes material design principles for incorporating anti‐inflammatory steroids into lipid nanoparticles to reduce LNP‐induced inflammation while retaining mRNA delivery. Results are validated in vitro and in three animal models of inflammation and autoimmunity in vivo.
Ajay S. Thatte   +21 more
wiley   +1 more source

Large Progressive Right Coronary Artery Aneurysm Secondary to IgG4 Disease. [PDF]

open access: yesJACC Case Rep
Khan M   +5 more
europepmc   +1 more source

Propriétés immunosuppressives des cellules souches mésenchymateuses

open access: yes, 2003
International ...
Djouad, Farida   +6 more
core  

Anisotropic Masked Mycobacterium Potentiates Amplified Antitumor Trained Immunity via Spleen Targeting and Myelopoiesis Conversion

open access: yesAdvanced Materials, EarlyView.
An engineered Trojan Mycobacterium, developed via a “peeling‐off and masking‐up” strategy, functions as a powerful splenic myelopoiesis converter. This spleen‐targeted nanomedicine induces trained immunity to reprogram immunosuppressive myeloid reservoirs into antitumoral effectors.
Jin‐Ho Choi   +5 more
wiley   +1 more source

Incidence of Endophthalmitis after Cataract Surgery in the Setting of Uveitis and Immunosuppressive Therapy within the IRIS® Registry. [PDF]

open access: yesOphthalmology
Ghoraba HH   +6 more
europepmc   +1 more source

Advanced Materials for Biologics Delivery to Brain Tumors

open access: yesAdvanced Materials, EarlyView.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy